Immutep Ltd Total Assets

Latest as of June 2025: AU$156.98 Million AUD ≈ $111.08 Million USD

Immutep Ltd total assets. Based on the latest financial reports, Immutep Ltd (IMM) holds total assets worth AU$156.98 Million AUD (≈ $111.08 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Immutep Ltd (IMM) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Immutep Ltd (2000–2025)

Total assets of Immutep Ltd from 2000 to 2025. This chart illustrates how Immutep Ltd's total assets have evolved over time, based on quarterly financial data. See Immutep Ltd stock price for real-time trading data and today's change.

Immutep Ltd - Asset Composition Analysis

Immutep Ltd Total Assets Breakdown (June 2025)

Immutep Ltd total assets breakdown as of June 2025. Immutep Ltd's total assets of AU$156.98 Million consist of 95.0% current assets and 5.0% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$17.26 Million	42.9%
Accounts Receivable	AU$7.46K	0.0%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$569.48K	0.4%
Intangible Assets	AU$7.09 Million	4.5%
Goodwill	AU$109.96K	0.1%

Asset Composition Trend (2000–2025)

This chart illustrates how Immutep Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Immutep Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Immutep Ltd's current assets represent 95.0% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 42.9% of total assets in 2025, up from 32.8% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is cash and equivalents at 42.9% of total assets.

Immutep Ltd Competitors by Total Assets

Key competitors of Immutep Ltd based on total assets are shown below.

Company	Country	Total Assets
argenx NV ADR NASDAQ:ARGX	USA	$10.03 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Ascendis Pharma AS NASDAQ:ASND	USA	$2.01 Billion
Summit Therapeutics PLC NASDAQ:SMMT	USA	$752.18 Million
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	USA	$1.26 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
Verona Pharma PLC ADR NASDAQ:VRNA	USA	$572.87 Million
3SBio Inc F:83B	Germany	€36.25 Billion

Immutep Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	11.69	18.25	9.26
Quick Ratio	11.69	18.25	9.26
Cash Ratio	1.35	6.38	4.02
Working Capital	AU$136.34 Million	AU$180.86 Million	AU$27.79 Million

Immutep Ltd - Advanced Valuation Insights

This section examines the relationship between Immutep Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.79
Latest Market Cap to Assets Ratio	0.14
Asset Growth Rate (YoY)	-22.1%
Total Assets	AU$156.98 Million
Market Capitalization	$21.87 Million USD

Valuation Analysis

Below Book Valuation: The market values Immutep Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Immutep Ltd's assets decreased by 22.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Immutep Ltd (2000–2025)

The table below shows the annual total assets of Immutep Ltd from 2000 to 2025.

Year	Total Assets	Change
2025-06-30	AU$156.98 Million ≈ $111.08 Million	-22.12%
2024-06-30	AU$201.58 Million ≈ $142.63 Million	+36.71%
2023-06-30	AU$147.45 Million ≈ $104.33 Million	+44.32%
2022-06-30	AU$102.17 Million ≈ $72.29 Million	+24.55%
2021-06-30	AU$82.03 Million ≈ $58.04 Million	+76.04%
2020-06-30	AU$46.60 Million ≈ $32.97 Million	+14.94%
2019-06-30	AU$40.54 Million ≈ $28.69 Million	-13.74%
2018-06-30	AU$47.00 Million ≈ $33.25 Million	+34.42%
2017-06-30	AU$34.96 Million ≈ $24.74 Million	-17.84%
2016-06-30	AU$42.55 Million ≈ $30.11 Million	+37.34%
2015-06-30	AU$30.98 Million ≈ $21.92 Million	+22.09%
2014-06-30	AU$25.38 Million ≈ $17.96 Million	-22.66%
2013-06-30	AU$32.81 Million ≈ $23.22 Million	-21.14%
2012-06-30	AU$41.61 Million ≈ $29.44 Million	-27.81%
2011-06-30	AU$57.64 Million ≈ $40.78 Million	+203.19%
2010-06-30	AU$19.01 Million ≈ $13.45 Million	+663.62%
2009-06-30	AU$2.49 Million ≈ $1.76 Million	-11.75%
2008-06-30	AU$2.82 Million ≈ $2.00 Million	-35.27%
2007-06-30	AU$4.36 Million ≈ $3.08 Million	-40.78%
2006-06-30	AU$7.36 Million ≈ $5.21 Million	-19.40%
2005-06-30	AU$9.13 Million ≈ $6.46 Million	+58.31%
2004-06-30	AU$5.77 Million ≈ $4.08 Million	+45.36%
2003-06-30	AU$3.97 Million ≈ $2.81 Million	-33.04%
2002-06-30	AU$5.93 Million ≈ $4.19 Million	+39.63%
2001-06-30	AU$4.24 Million ≈ $3.00 Million	+102.58%
2000-06-30	AU$2.10 Million ≈ $1.48 Million	--

About Immutep Ltd

AU:IMM Australia Biotechnology

Market Cap

$21.87 Million

AU$30.91 Million AUD

Market Cap Rank

#24646 Global

#997 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.46

All Time High

AU$0.68